2021 Pathology Review: Gynecologic, Breast and Soft Tissue for the General Pathologist

2021 Pathology Review: Gynecologic, Breast and Soft Tissue for the General Pathologist

90 $

Delivery time: Maximum to 1 hours

Category:

2021 Pathology Review: Gynecologic, Breast and Soft Tissue for the General Pathologist

PROGRAM

Session 1

Serous Neoplasia of the Ovary

Mara H. Rendi, M.D., Ph.D.
 
Endometrial Neoplasia, Subtypes, Mimics and Molecular Testing
Mara H. Rendi, M.D., Ph.D.
 
Session 2

Sex Cord Stromal Tumors of the Gynecologic Track

Mara H. Rendi, M.D., Ph.D.
 
Session 3

Problematic Issues in Breast Core Needle Biopsies

Stuart J. Schnitt, M.D.
 
Inflammatory and Reactive Lesions of the Breast
Stuart J. Schnitt, M.D.
 
Session 4

Evaluation of the Post-Neoadjuvant Chemotherapy Breast Specimen

Stuart J. Schnitt, M.D.
 
The Spectrum of Triple Negative Breast Cancer
Stuart J. Schnitt, M.D.
 
Pseudolymphomas
Alejandro Ariel Gru, M.D.
 
Session 5

Update in Cutaneous Lymphomas in the WHO Classification

Alejandro Ariel Gru, M.D.
 
Superficial Mesenchymal Tumors in the Pediatric Setting
Alejandro Ariel Gru, M.D.

Session 6

Cutaneous Histiocytic Neoplasms

Alejandro Ariel Gru, M.D.
 
The Challenging Melanocytic Lesions in the Pediatric Population
Alejandro Ariel Gru, M.D.
 
Session 7

Challenging Cervical Lesions of the Uterus

Mara H. Rendi, M.D., Ph.D.
 
Mesenchymal Tumors of the Uterus
Mara H. Rendi, M.D., Ph.D.

Session 8

Practical Placental Pathology

Mara H. Rendi, M.D., Ph.D.
 
Session 9

Problematic In Situ Lesions of the Breast

Stuart J. Schnitt, M.D.
 
Spindle Cell and Vascular Lesions of the Breast 
Stuart J. Schnitt, M.D.
 
Session 10

The Continuing Dilemma of Ductal Carcinoma in Situ

Stuart J. Schnitt, M.D.
 
Molecular Testing & ER/PR, HER2 Guidelines in the Management of Patients with Breast Cancer
Stuart J. Schnitt, M.D.

Related Products